Nomathemba Chandiwana to Cohort Studies
This is a "connection" page, showing publications Nomathemba Chandiwana has written about Cohort Studies.
Connection Strength
0,039
-
AGILE: a seamless phase I/IIa platform for the rapid evaluation of candidates for COVID-19 treatment: an update to the structured summary of a study protocol for a randomised platform trial letter. Trials. 2021 Jul 26; 22(1):487.
Score: 0,039